Article Details

Abeona Therapeutics (NASDAQ:ABEO) Given “Buy” Rating at Cantor Fitzgerald

Retrieved on: 2019-06-08 09:41:15

Tags for this article:

Click the tags to see associated articles and topics

Abeona Therapeutics (NASDAQ:ABEO) Given “Buy” Rating at Cantor Fitzgerald. View article details on hiswai:

Excerpt

<div><b>Schonfeld Strategic Advisors</b> LLC lifted its stake in shares of Abeona Therapeutics by 2.7% during the first quarter. <b>Schonfeld Strategic Advisors</b> LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up